These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20721357)

  • 1. Ghrelin in chronic kidney disease.
    Cheung WW; Mak RH
    Int J Pept; 2010; 2010():. PubMed ID: 20721357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?
    DeBoer MD
    Mol Cell Endocrinol; 2011 Jun; 340(1):97-105. PubMed ID: 21354462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin and cachexia in chronic kidney disease.
    Suzuki H; Asakawa A; Amitani H; Nakamura N; Inui A
    Pediatr Nephrol; 2013 Apr; 28(4):521-6. PubMed ID: 22760416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
    Akamizu T; Kangawa K
    Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease.
    Mak RH; Cheung W; Cone RD; Marks DL
    Pediatr Nephrol; 2005 Mar; 20(3):427-31. PubMed ID: 15662537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin receptor regulates appetite and satiety during aging in mice by regulating meal frequency and portion size but not total food intake.
    Lin L; Nuotio-Antar AM; Ma X; Liu F; Fiorotto ML; Sun Y
    J Nutr; 2014 Sep; 144(9):1349-55. PubMed ID: 24991043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.
    Sun Y; Wang P; Zheng H; Smith RG
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4679-84. PubMed ID: 15070777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass.
    Liu H; Zang P; Lee II; Anderson B; Christiani A; Strait-Bodey L; Breckheimer BA; Storie M; Tewnion A; Krumm K; Li T; Irwin B; Garcia JM
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1280-1295. PubMed ID: 34264027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.
    Howick K; Griffin BT; Cryan JF; Schellekens H
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Targeting the Ghrelin Pathway.
    Colldén G; Tschöp MH; Müller TD
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ghrelin in anorexia-cachexia syndromes.
    Guillory B; Splenser A; Garcia J
    Vitam Horm; 2013; 92():61-106. PubMed ID: 23601421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome.
    Fujitsuka N; Uezono Y
    Front Pharmacol; 2014; 5():271. PubMed ID: 25540621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
    Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
    Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
    Cheung WW; Mak RH
    Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of ghrelin as a treatment for cachexia syndromes.
    DeBoer MD
    Nutrition; 2008 Sep; 24(9):806-14. PubMed ID: 18725076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
    Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
    PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms and Health Benefits of Ghrelin: A Narrative Review.
    Jiao ZT; Luo Q
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs.
    Rhodes L; Zollers B; Wofford JA; Heinen E
    Vet Med Sci; 2018 Feb; 4(1):3-16. PubMed ID: 29468076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin and leptin pathophysiology in chronic kidney disease.
    Gunta SS; Mak RH
    Pediatr Nephrol; 2013 Apr; 28(4):611-6. PubMed ID: 23229444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation
    Liu H; Luo J; Guillory B; Chen JA; Zang P; Yoeli JK; Hernandez Y; Lee II; Anderson B; Storie M; Tewnion A; Garcia JM
    Oncotarget; 2020 Sep; 11(35):3286-3302. PubMed ID: 32934774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.